Assessment for screening for prostate cancer in Gunma
Not Applicable
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000043131
- Lead Sponsor
- Department of Urology, Gunma University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
1)All inhabitants living in the municipalities decided not to participate in the present study (clarified the intention of opt-out for the present study) 2)All individuals who clarified the intention of opt-out for the present study (excluding data for the case-control study and the retrospective cohort study) 3)All individuals who died or could not clarify their own intention and whom direct relatives clarified the intention of opt-out for the present study (excluding data for the case-control study and the retrospective cohort study) 4)Men whom physicians or researchers recommended to exclude from the present study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Case control study in Isesaki city (old Isesaki city; original community before municipal merger) and in Gunma prefecture excluding Isesaki city. Investigating relationship between PSA-based screening history and death due to prostate cancer (estimating odds ratio) in men aged below 85 years old (the age of having life expectancy of 7 years or longer) Candidates for influencing factor on screening histories are followings; 1)Population-based PSA screening history before cancer detection: none vs. present 2)Diagnostic opportunity (data from MN report): screening vs. outpatient clinic due to having any urinary symptoms 3)Population-based PSA screening history within 2 years before cancer detection: none vs. present 4)Population-based PSA screening history within 5 years before cancer detection: none vs. present 5)Population-based PSA screening history within 5 years before cancer detection: none or only once vs. present more than once
- Secondary Outcome Measures
Name Time Method